Relationship between Plasmodium falciparum malaria prevalence, genetic diversity and endemic Burkitt lymphoma in Malawi

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Johnston, W Thomas ^a   Mutalima, Nora ^a   Sun, David ^b   Emmanuel, Benjamin ^c   Bhatia, Kishor ^c   Aka, Peter ^c   Wu, Xiaolin ^b   Borgstein, E ^d   Liomba, G N ^d   Kamiza, Steve ^d   Mkandawire, Nyengo ^d   Batumba, Mkume ^d   Carpenter, Lucy M ^e   Jaffe, Harold ^e   Molyneux, Elizabeth M ^d   Goedert, James J ^c   Soppet, Daniel ^b   Newton, Robert ^a   Mbulaiteye, Sam M ^c  

^a UNIVERSITY OF YORK   (United Kingdom)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Queen Elizabeth Hospital   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOAL DNA;

ADOLESCENT; BURKITT LYMPHOMA; CASE CONTROL STUDY; CHILD; COMPLICATION; FEMALE; GENETIC VARIATION; GENETICS; GENOTYPE; HUMAN; INFANT; MALARIA, FALCIPARUM; MALAWI; MALE; NEWBORN; ODDS RATIO; PARASITOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; BURKITT LYMPHOMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA, PROTOZOAN; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALAWI; MALE; ODDS RATIO; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE;

EID: 84892765542     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03741     Document Type: Article

References (31)

1. Rochford, R., Cannon, M. J. & Moormann, A. M. Endemic Burkitt's lymphoma: A polymicrobial disease? Nat Rev Microbiol 3, 182-187 (2005). (Pubitemid 40207598)
2. Mutalima, N. et al. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: Results from a case-control study. PloS One 3, e2505 (2008).
3. Mutalima, N. et al. Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi - preliminary findings. Infect Agent and Cancer 5, 5 (2010).
4. Carpenter, L. M. et al. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: A case-control study in uganda. Int J Cancer 122, 1319-1323 (2008). (Pubitemid 351287232)
5. Bouvard, V. et al. Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol 13, 339-340 (2012).
6. Aka, P. et al. Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody response. Blood 122, 629-635 (2013).
7. Guech-Ongey, M. et al. Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana. Int J Cancer 130, 1908-1914 (2012).
8. Ziegler, J. L. et al. Burkitt's lymphoma and malaria. Trans R Soc Trop Med Hyg 66, 285-291 (1972).
9. Feorino, P. M.&Mathews, H. M. Malaria antibody levels in patients with Burkitt's lymphoma. Am J Trop Med Hyg 23, 574-576 (1974).
10. Asito, A. S. et al. Elevated anti-zta igg levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: Acase control study. Infect Agent and Cancer 5, 13 (2010).
11. Emmanuel, B. et al. African Burkitt lymphoma: Age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg 84, 397-401 (2011).
12. Gardiner, C., Biggar, R. J., Collins, W. E. & Nkrumah, F. K. Malaria in urban and rural areas of southern Ghana: A survey of parasitaemia, antibodies, and antimalarial practices. Bull World Health Organ 62, 607-613 (1984). (Pubitemid 14043250)
13. Okello, P. E. et al. Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg 75, 219-225 (2006). (Pubitemid 46941334)
14. O'Meara, W. P., Mangeni, J. N., Steketee, R. & Greenwood, B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis 10, 545-555 (2010).
15. Branch, O. H. et al. Plasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay cohort project. Infect Immun 69, 7783-7792 (2001). (Pubitemid 33086609)
16. Daniels, R. et al. A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking. Malar J 7, 223 (2008).
17. Rainey, J. J. et al. Spatial distribution of Burkitt's lymphoma in Kenya and association with malaria risk. Trop Med Intern Health 12, 936-943 (2007). (Pubitemid 47245827)
18. Iversen, U., Iversen, O. H., Bluming, A. Z., Ziegler, J. L. & Kyalwasi, S. Cell kinetics of african cases of Burkitt lymphoma. A preliminary report. Eur J Cancer 8, 305-308 (1972).
19. Williams, E. H., Day, N. E. & Geser, A. G. Seasonal variation in onset of Burkitt's lymphoma in the west nile district of Uganda. Lancet 2, 19-22 (1974).
20. Ofosu-Okyere, A. et al. Novel Plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in Ghanaian children during the transition into the high transmission season. Parasitology 123, 113-123 (2001). (Pubitemid 32701833)
21. Farnert, A., Rooth, I., Svensson, Snounou, G. & Bjorkman, A. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in tanzanian children. J Infect Dis 179, 989-995 (1999). (Pubitemid 29159346)
22. Donati, D. et al. Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator. J Immunol 177, 3035-3044 (2006). (Pubitemid 44277820)
23. Simone, O. et al. TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) CIDR1alpha-driven human polyclonal B-cell activation. Acta Trop 119, 144-150 (2011).
24. Weiss, G. E. et al. Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 183, 2176-2182 (2009).
25. Smith, J. D. et al. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82, 101-110 (1995).
26. Donati, D. et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun 72, 5412-5418 (2004). (Pubitemid 39223429)
27. Lam, K. M., Syed, N., Whittle, H. & Crawford, D. H. Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 337, 876-878 (1991).
28. Chene, A. et al. Endemic Burkitt's lymphoma as a polymicrobial disease: New insights on the interaction between Plasmodium falciparum and Epstein-Barr virus. Sem Cancer Biol 19, 411-420 (2009).
29. Grimes, D. A. & Schulz, K. F. Descriptive studies: What they can and cannot do. Lancet 359, 145-149 (2002). (Pubitemid 34112548)
30. Crompton, P. D. et al. A prospective analysis of the ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci USA 107, 6958-6963 (2010).
31. Milner, D. A. Jr. et al. Human cerebral malaria and Plasmodium falciparum genotypes in Malawi. Malaria J 11, 35 (2012).